MI-3454
MI-3454 is an orally active, selective and potent inhibitor of Menin-MLL1 interaction that inhibits the proliferation and induces differentiation of acute leukemia cells with MLL1 translocation or NPM1 mutation.MI-3454 induces complete remission or regression of leukemia in a mouse model of leukemia with MLL1 rearrangement or NPM1 mutation through the down-regulation of key genes involved in leukemogenesis. complete remission or remission.
Product Specifications
CAS Number
2134169-43-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
636.73
Molecular Formula
C32H35F3N8OS
Notes
Research use only, not for human use.
Receptor
Histone Methyltransferase
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6122210-01 0.1 mL
Cytokeratin 17 (Cytokeratin-17, CK 17, CK17, CK-17, Keratin 17, Keratin-17, Keratin Type I Cytoskeletal 17) (FITC)
Sign In for Pricing
View Details MBS6122210-02 5x 0.1 mL
Cytokeratin 17 (Cytokeratin-17, CK 17, CK17, CK-17, Keratin 17, Keratin-17, Keratin Type I Cytoskeletal 17) (FITC)
Sign In for Pricing
View Details 
MBS1045499 Inquire
Recombinant Saccharomyces cerevisiae Spindle pole body component 110 (SPC110) , partial
Sign In for Pricing
View Details